Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Sales, net	$ 43,710	$ 46,954
Cost of sales	38,722	40,287
Gross profit	4,988	6,667
Selling and administrative expenses	3,294	3,480
Operating income	1,694	3,187
Other income (expense), net:
Interest expense	(926)	(911)
Change in fair value of derivative liability	494	(427)
Impairment on investment in iBio Stock	(358)	(36)
Other income, net	101	43
Total other expense, net	(689)	(1,331)
Income before income taxes	1,005	1,856
Income tax expense (benefit) , net	326	(490)
Net income	679	2,346
Expenses related to Convertible Debt - CD Financial, LLC:
Change in fair value of derivative liability	(494)	427
Interest expense, net of taxes	216	195
Amortization of prepaid financing costs, net of taxes	6	6
Accretion of Convertible debt	39	39
Diluted net income	$ 446	$ 3,013
Basic net income per common share (in dollars per share)	$ 0.03	$ 0.11
Diluted net income per common share (in dollars per share)	$ 0.02	$ 0.10
Weighed average common shares outstanding - basic (in shares)	21,135,174	21,117,078
Add: Equivalent shares outstanding - stock options (in shares)	951,399	825,893
Shares issuable upon conversion of Convertible Debt CD Financial, LLC (in shares)	8,230,769	8,230,769
Weighted average common shares outstanding - diluted (in shares)	30,317,342	30,173,740